Agenda

  • Friday, May 16, 2025

8–8:15 a.m.

Welcome

David Skolnick, MD

BLOCK 1: AORTIC STENOSIS

8:15–8:20 a.m.

Case Presentation – Young Patient with Severe AS

Seshu Rao, MD

8:20–8:35 a.m.

Timing for AVR: New Approaches to the Asymptomatic Patient

Adnan Chhatriwalla, MD

8:35–9 a.m.

Understanding High Gradients Post-TAVR

Howard Hermann, MD

9–9:20 a.m.

Advanced in Aortic Valve Surgery

Yoshi Kaneko, MD

9:20–9:40 a.m.

Lifetime Management of Aortic Valve Disease

Chetan Huded, MD

9:40–10 a.m.

Case Conclusion and Discussion

Seshu Rao, MD

10–10:20 a.m.

BREAK

BLOCK 2: MITRAL VALVE

10:20–10:35 a.m.

Echo – Mechanisms and Grading Severity of MR

Vrinda Trivedi, MD

10:35–10:40 a.m.

Case Presentation – Challenging Mitral Intervention

Rachel Goodwin, DO

10:40–11 a.m.

Evolving Indications for M-TEER

Alan Zajarias, MD

11–11:20 a.m.

Minimally Invasive Surgery for MV Disease

TBD

11:20–11:35 a.m.

Challenges of Managing MAC

Keith Allen, MD

11:35–11:55 a.m.

Novel Devices for Mitral Valve Intervention

John Saxon, MD

11:50 a.m.–12:15 p.m.

Case Conclusion and Discussion

Rachel Goodwin, DO

12:15–1 p.m.

LUNCH

BLOCK 3: TRICUSPID REGURGITATION

1–1:15 p.m.

Echo – Mechanisms and Grading Severity of TR

David Skolnick, MD

1:15–1:20 p.m.

Case Presentation – Managing Severe TR

Peter Tadros, MD

1:20–1:40 p.m.

Improving Health Status for Patients with TR

Suzanne Arnold, MD

1:40–2:05 p.m.

Pros and Cons of Transcatheter Technologies for TR

Rishi Puri, MD

2:05– 2:20 p.m.

Surgical Intervention for TR

J. Russel Davis, MD

2:20– 2:40 p.m.

Case Conclusion and Discussion

Peter Tadros, MD

2:40–3 p.m.

BREAK

BLOCK 4: CHALLENGES AHEAD

3–3:20 p.m.

Electrosurgery in Structural Heart Disease

Elizabeth Grier, MD

3:20–3:35 p.m.

Landscape of Interventional Echocardiography

Kyle Lehenbauer, MD

3:35–3:55 p.m.

Challenging Case and Discussion

Ajay Eshcol, MD

3:55–4:10 p.m.

APP Role on the Valve Team

Sarah Heavey, RN, AGACNP

4:10–4:35 p.m.

Unanswered Questions in the Diagnosis and Management of Valvular Heart Disease

David Cohen, MD

4:35–4:55 p.m.

Q&A